NUE three-lens brief
Evidence-based stock research on NUE. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 22.2pp over 30 days. · Trading at 98% of its 52-week range — near the top of the band.
- Trading at 98% of its 52-week range — near the top of the band.
- RSI at 83 — technically overbought.
- Outperforming SPY by 22.2pp over 30 days.
- Analyst mean target $192.55 — 10% below current (13 analysts).
- Negative free cash flow last quarterly (-$903.37M).
NUE closed at $214.29 (+0.63%) as of 2026-04-25. Market cap: $48.80B. P/E (trailing) 28.5. Positives: outperforming SPY by 22.2pp over 30 days.. Concerns: trading at 98% of its 52-week range — near the top of the band.; rSI at 83 — technically overbought.. Last quarter: Revenue $7.69B, net income $378.00M, free cash flow -$903.37M.
Why three lenses on NUE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine NUEacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/NUE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath NUE brief"></iframe>